Neuraxis, Inc. (NRXS)

Neuraxis, Inc. (NRXS) is a Biotechnology company in the Healthcare sector listed on the AMEX.

As of Oct 23, 2026: market cap $87M; returns 1 day -2.6%, 1 week -3.9%, 1 year +93.7%.

Neuraxis Inc. (NRXS) is a medical technology company that focuses on developing and commercializing neuromodulation therapies for chronic and debilitating conditions in both children and adults. Their main product is IB-Stim, a percutaneous electrical nerve field stimulation (PENFS) system.

Groups NRXS belongs to

• Healthcare
• Medical Devices
• Healthcare Technology
• Digestive Health
• Commercial Stage
• Gastroenterology
• Neuroscience
• Pain Management
• Healthcare Innovation
• Technology Sector

NRXS financial model: income statement, cash flow and balance sheet